Intercell Japanese Encephalitis Vaccine May Launch In 2007
Novartis would market the product in the U.S.; a BLA is planned for later this year following positive Phase III safety results.
Novartis would market the product in the U.S.; a BLA is planned for later this year following positive Phase III safety results.